Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study
Medical Oncology · 2025
DOI: 10.1007/s12032-025-03205-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Zuohao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Flavonoids, Tumor Microenvironment, Melanoma, Skin Neoplasms. Die Arbeit nennt 78 Literaturangaben. Gefördert von: LZU-IMPCAS cooperation.
Abstract (Originalsprache)
The occurrence and advancement of skin cutaneous melanoma (SKCM) is closely associated with tumor microenvironment (TME). Evaluating the condition of immune cell infiltration is pivotal to the comprehension regarding the features of TME in SKCM. Baicalin has been demonstrated to have anti-tumor effects by regulating the TME in tumors. However, its pharmacological potential in melanoma still needs to be elucidated. In this study, through unsupervised clustering analysis and network pharmacology, 32 potential baicalin targets have been identified. The prognostic model effectively stratifies patients, and an individualized clinical prediction model can be developed from it. Single-cell analysis demonstrated the expression of prognostic targets was associated with TME and mainly accumulated in mono/macro subset. Finally, in vitro experiments demonstrated that baicalin significantly reduced the viability, proliferation, and migration capabilities of melanoma cells. Additionally, baicalin promoted pro-inflammatory polarization of macrophages under co-culture with melanoma cells and baicalin exerted relatively high biological safety. In conclusion, this study demonstrates that baicalin inhibits melanoma by modulating the TME and establishes a prognostic model with predictive potential. These findings expand the therapeutic potential of baicalin and provide novel insights for melanoma treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
- School of Life Sciences, Lanzhou University, Lanzhou, 730000, China. linc@lzu.edu.cn.
Förderung
- LZU-IMPCAS cooperation
Zitieren
APA
Liu, Z., Dang, B., Wang, X., Liu, Y., Wang, C., & Lin, C. (2025). Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study. Medical Oncology. https://doi.org/10.1007/s12032-025-03205-2
Vancouver
Liu Z, Dang B, Wang X, Liu Y, Wang C, Lin C. Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study. Medical Oncology. 2025. doi:10.1007/s12032-025-03205-2
BibTeX
@article{Liu2025,
author = {Liu, Zuohao and Dang, Bingrong and Wang, Xingsheng and Liu, Yuhan and Wang, Chunming and Lin, Changjun},
title = {Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study},
journal = {Medical Oncology},
year = {2025},
doi = {10.1007/s12032-025-03205-2}
}
EUVIMED